Repligen Valuation
| RGEN Stock | USD 146.11 4.12 2.74% |
At this time, the company appears to be fairly valued. Repligen holds a recent Real Value of $150.28 per share. The prevailing price of the company is $146.11. Our model determines the value of Repligen from analyzing the company fundamentals such as Operating Margin of 0.07 %, shares outstanding of 56.29 M, and Return On Equity of 9.0E-4 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Repligen's valuation include:
Price Book 4.0837 | Enterprise Value | Enterprise Value Ebitda 69.8006 | Price Sales 11.9461 | Forward PE 80.6452 |
Fairly Valued
Today
Please note that Repligen's price fluctuation is very steady at this time. Calculation of the real value of Repligen is based on 3 months time horizon. Increasing Repligen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Repligen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Repligen Stock. However, Repligen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 146.11 | Real 150.28 | Target 190.89 | Hype 150.46 | Naive 141.38 |
The intrinsic value of Repligen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Repligen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Repligen helps investors to forecast how Repligen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Repligen more accurately as focusing exclusively on Repligen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Repligen's intrinsic value based on its ongoing forecasts of Repligen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Repligen's closest peers.
Repligen Cash |
|
Repligen Revenue by Product
Repligen Total Value Analysis
Repligen is at this time forecasted to have valuation of 8.45 B with market capitalization of 8.46 B, debt of 686.25 M, and cash on hands of 596.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Repligen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.45 B | 8.46 B | 686.25 M | 596.51 M |
Repligen Investor Information
About 94.0% of the company shares are owned by institutional investors. The book value of Repligen was at this time reported as 37.01. The company has Price/Earnings To Growth (PEG) ratio of 2.59. Repligen last dividend was issued on the 29th of October 2010. Based on the analysis of Repligen's profitability, liquidity, and operating efficiency, Repligen is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Repligen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Repligen has an asset utilization ratio of 22.42 percent. This suggests that the Company is making $0.22 for each dollar of assets. An increasing asset utilization means that Repligen is more efficient with each dollar of assets it utilizes for everyday operations.Repligen Profitability Analysis
Considering Repligen's profitability and operating efficiency indicators, Repligen may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Repligen's ability to earn profits and add value for shareholders.Net Loss | First Reported 1985-09-30 | Previous Quarter 14.9 M | Current Value 14.9 M | Quarterly Volatility 170.9 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.68 | 0.5 |
|
|
For Repligen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Repligen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Repligen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Repligen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Repligen over time as well as its relative position and ranking within its peers.
Repligen Earnings per Share Projection vs Actual
The next projected EPS of Repligen is estimated to be 0.51875 with future projections ranging from a low of 0.44 to a high of 0.6175. Repligen's most recent 12-month trailing earnings per share (EPS TTM) is at 0.02. Please be aware that the consensus of earnings estimates for Repligen is based on EPS before non-recurring items and includes expenses related to employee stock options.Repligen Earnings Estimation Breakdown
The calculation of Repligen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Repligen is estimated to be 0.51875 with the future projection ranging from a low of 0.44 to a high of 0.6175. Please be aware that this consensus of annual earnings estimates for Repligen is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.44 Lowest | Expected EPS | 0.62 Highest |
Repligen Earnings Projection Consensus
Suppose the current estimates of Repligen's value are higher than the current market price of the Repligen stock. In this case, investors may conclude that Repligen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Repligen's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 21 | 82.97% | 0.0 | 0.51875 | 0.02 |
Repligen Ownership Allocation
The majority of Repligen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Repligen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Repligen. Please pay attention to any change in the institutional holdings of Repligen as this could imply that something significant has changed or is about to change at the company.Repligen Profitability Analysis
The company reported the previous year's revenue of 634.44 M. Net Loss for the year was (25.51 M) with profit before overhead, payroll, taxes, and interest of 365.19 M.About Repligen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Repligen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Repligen based exclusively on its fundamental and basic technical indicators. By analyzing Repligen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Repligen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Repligen. We calculate exposure to Repligen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Repligen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 315.8 M | 532 M | |
| Pretax Profit Margin | (0.04) | (0.04) | |
| Operating Profit Margin | (0.05) | (0.05) | |
| Net Loss | (0.04) | (0.04) | |
| Gross Profit Margin | 0.50 | 0.68 |
Repligen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 55.9 M | |
| Quarterly Earnings Growth Y O Y | 1.6 | |
| Forward Price Earnings | 80.6452 |
Repligen Current Valuation Indicators
Repligen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Repligen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Repligen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Repligen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Repligen's worth.When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.6 | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth 0.219 | Return On Assets |
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.